Real-world study of patients treated with the Carillon Mitral Contour System® as standard of care in a single center: Marien Hospital Witten, Germany

• 204 consecutive cases – 99% of attempted patients treated
• 201 patients evaluated – baseline vs 3 months
• Retrospective, non-randomized analysis of cases
• Largest single center published cohort of Carillon® patients worldwide

Conclusions:

• No intervention-related deaths
• A high success rate
• An excellent safety profile
• A rapid learning curve
• Large improvements in mechanistic variables
• High clinical benefits
• Ability to combine with alterative therapies
• Preservation of all possible future therapy options (including TEER and CRT)